Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
46,239,275
-
Total 13F shares
-
14,672,947
-
Share change
-
+680,264
-
Total reported value
-
$381,998,824
-
Put/Call ratio
-
169%
-
Price per share
-
$26.12
-
Number of holders
-
83
-
Value change
-
+$28,259,689
-
Number of buys
-
51
-
Number of sells
-
24
Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q2 2020
As of 30 Jun 2020,
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,672,947 shares.
The largest 10 holders included
MENORA MIVTACHIM HOLDINGS LTD., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., CREDIT SUISSE AG/, Wildcat Capital Management, LLC, Phoenix Holdings Ltd., Migdal Insurance & Financial Holdings Ltd., Clal Insurance Enterprises Holdings Ltd, STATE STREET CORP, and Horton Capital Management, LLC.
This page lists
83
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.